サマリー

市場分析と洞察。世界と中国のB型肝炎ヒト免疫グロブリン市場
当レポートでは、世界および中国のB型肝炎ヒト免疫グロブリン市場に焦点を当てています。
2020年のB型肝炎ヒト免疫グロブリンの世界市場規模はXX百万米ドルで、2021年から2027年の間にXX％のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。中国では、B型肝炎ヒト免疫グロブリンの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界のB型肝炎ヒト免疫グロブリンの範囲と市場規模
B型肝炎ヒト免疫グロブリン市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のB型肝炎ヒト免疫グロブリン市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
中国市場については、2016-2027年のB型肝炎ヒト免疫グロブリン市場規模をプレイヤー別、タイプ別、アプリケーション別に分析しています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
100IU
200IU
400IU

用途別セグメント
麻疹の予防
B型肝炎ウイルス感染症の予防
A型肝炎ウイルス感染症の予防
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE

会社別
Biotest
ADMAバイオロジクス
サンクインブラッド
バイオプロダクツ研究所
バクスター
CSL
バイエル
Grifols
オクタファーマ
花蘭咲
中国バイオロジック
天壇バイオロジック
双林バイオファーマシー（Shuanglin Bio-pharmacy
四川遠大修陽
上海生物学研究所
花蘭
上海RAAS血液製剤
中国大企業
南越生物製薬
博雅生物医薬集団
東路生物医薬
山東泰邦生物医薬股份有限公司
広東双林生物医薬
成都栄勝製薬
深圳偉光生物製薬
緑十字（中国）生物製剤
シノファーム

ページTOPに戻る

目次

1 Study Coverage
1.1 Hepatitis B Human Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Type
1.2.2 100IU
1.2.3 200IU
1.2.4 400IU
1.3 Market by Application
1.3.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Application
1.3.2 Measles Prevention
1.3.3 Prevention of Hepatitis B Virus Infection
1.3.4 Hepatitis A Virus Infection
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Hepatitis B Human Immunoglobulin Market Size, Estimates and Forecasts
2.1.1 Global Hepatitis B Human Immunoglobulin Revenue 2016-2027
2.1.2 Global Hepatitis B Human Immunoglobulin Sales 2016-2027
2.2 Global Hepatitis B Human Immunoglobulin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Hepatitis B Human Immunoglobulin Historical Market Size by Region (2016-2021)
2.3.1 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Region (2022-2027)
2.4.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Region (2022-2027)

3 Global Hepatitis B Human Immunoglobulin Competitor Landscape by Players
3.1 Global Top Hepatitis B Human Immunoglobulin Manufacturers by Sales
3.1.1 Global Hepatitis B Human Immunoglobulin Sales by Manufacturer (2016-2021)
3.1.2 Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Hepatitis B Human Immunoglobulin Manufacturers by Revenue
3.2.1 Key Hepatitis B Human Immunoglobulin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Hepatitis B Human Immunoglobulin Revenue by Manufacturers (2016-2021)
3.2.3 Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hepatitis B Human Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Hepatitis B Human Immunoglobulin Revenue in 2020
3.2.6 Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Hepatitis B Human Immunoglobulin Price by Manufacturers
3.4 Global Hepatitis B Human Immunoglobulin Manufacturing Base Distribution, Product Types
3.4.1 Hepatitis B Human Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepatitis B Human Immunoglobulin Product Type
3.4.3 Date of International Manufacturers Enter into Hepatitis B Human Immunoglobulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Hepatitis B Human Immunoglobulin Market Size by Type (2016-2021)
4.1.1 Global Hepatitis B Human Immunoglobulin Sales by Type (2016-2021)
4.1.2 Global Hepatitis B Human Immunoglobulin Revenue by Type (2016-2021)
4.1.3 Hepatitis B Human Immunoglobulin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Hepatitis B Human Immunoglobulin Market Size Forecast by Type (2022-2027)
4.2.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Type (2022-2027)
4.2.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Type (2022-2027)
4.2.3 Hepatitis B Human Immunoglobulin Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Hepatitis B Human Immunoglobulin Market Size by Application (2016-2021)
5.1.1 Global Hepatitis B Human Immunoglobulin Sales by Application (2016-2021)
5.1.2 Global Hepatitis B Human Immunoglobulin Revenue by Application (2016-2021)
5.1.3 Hepatitis B Human Immunoglobulin Price by Application (2016-2021)
5.2 Hepatitis B Human Immunoglobulin Market Size Forecast by Application (2022-2027)
5.2.1 Global Hepatitis B Human Immunoglobulin Sales Forecast by Application (2022-2027)
5.2.2 Global Hepatitis B Human Immunoglobulin Revenue Forecast by Application (2022-2027)
5.2.3 Global Hepatitis B Human Immunoglobulin Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027
6.1.1 China Hepatitis B Human Immunoglobulin Sales YoY Growth 2016-2027
6.1.2 China Hepatitis B Human Immunoglobulin Revenue YoY Growth 2016-2027
6.1.3 China Hepatitis B Human Immunoglobulin Market Share in Global Market 2016-2027
6.2 China Hepatitis B Human Immunoglobulin Market Size by Players (International and Local Players)
6.2.1 China Top Hepatitis B Human Immunoglobulin Players by Sales (2016-2021)
6.2.2 China Top Hepatitis B Human Immunoglobulin Players by Revenue (2016-2021)
6.3 China Hepatitis B Human Immunoglobulin Historic Market Review by Type (2016-2021)
6.3.1 China Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2021)
6.3.2 China Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2016-2021)
6.3.3 China Hepatitis B Human Immunoglobulin Price by Type (2016-2021)
6.4 China Hepatitis B Human Immunoglobulin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Hepatitis B Human Immunoglobulin Sales Forecast by Type (2022-2027)
6.4.2 China Hepatitis B Human Immunoglobulin Revenue Forecast by Type (2022-2027)
6.4.3 China Hepatitis B Human Immunoglobulin Price Forecast by Type (2022-2027)
6.5 China Hepatitis B Human Immunoglobulin Historic Market Review by Application (2016-2021)
6.5.1 China Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2021)
6.5.2 China Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2016-2021)
6.5.3 China Hepatitis B Human Immunoglobulin Price by Application (2016-2021)
6.6 China Hepatitis B Human Immunoglobulin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Hepatitis B Human Immunoglobulin Sales Forecast by Application (2022-2027)
6.6.2 China Hepatitis B Human Immunoglobulin Revenue Forecast by Application (2022-2027)
6.6.3 China Hepatitis B Human Immunoglobulin Price Forecast by Application (2022-2027)

7 North America
7.1 North America Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027
7.2 North America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
7.2.1 North America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021)
7.2.2 North America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Hepatitis B Human Immunoglobulin Market Facts & Figures by Region
8.2.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2016-2021)
8.2.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027
9.2 Europe Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
9.2.1 Europe Hepatitis B Human Immunoglobulin Sales by Country (2016-2021)
9.2.2 Europe Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027
10.2 Latin America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
10.2.1 Latin America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021)
10.2.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Hepatitis B Human Immunoglobulin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
11.2.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE

12 Company Profiles
12.1 Biotest
12.1.1 Biotest Corporation Information
12.1.2 Biotest Description and Business Overview
12.1.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Biotest Hepatitis B Human Immunoglobulin Products Offered
12.1.5 Biotest Recent Development
12.2 ADMA Biologics
12.2.1 ADMA Biologics Corporation Information
12.2.2 ADMA Biologics Description and Business Overview
12.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Products Offered
12.2.5 ADMA Biologics Recent Development
12.3 Sanquin Blood
12.3.1 Sanquin Blood Corporation Information
12.3.2 Sanquin Blood Description and Business Overview
12.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Products Offered
12.3.5 Sanquin Blood Recent Development
12.4 Bio Products Laboratory
12.4.1 Bio Products Laboratory Corporation Information
12.4.2 Bio Products Laboratory Description and Business Overview
12.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Products Offered
12.4.5 Bio Products Laboratory Recent Development
12.5 Baxter
12.5.1 Baxter Corporation Information
12.5.2 Baxter Description and Business Overview
12.5.3 Baxter Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Baxter Hepatitis B Human Immunoglobulin Products Offered
12.5.5 Baxter Recent Development
12.6 CSL
12.6.1 CSL Corporation Information
12.6.2 CSL Description and Business Overview
12.6.3 CSL Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CSL Hepatitis B Human Immunoglobulin Products Offered
12.6.5 CSL Recent Development
12.7 Bayer
12.7.1 Bayer Corporation Information
12.7.2 Bayer Description and Business Overview
12.7.3 Bayer Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bayer Hepatitis B Human Immunoglobulin Products Offered
12.7.5 Bayer Recent Development
12.8 Grifols
12.8.1 Grifols Corporation Information
12.8.2 Grifols Description and Business Overview
12.8.3 Grifols Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Grifols Hepatitis B Human Immunoglobulin Products Offered
12.8.5 Grifols Recent Development
12.9 Octapharma
12.9.1 Octapharma Corporation Information
12.9.2 Octapharma Description and Business Overview
12.9.3 Octapharma Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Octapharma Hepatitis B Human Immunoglobulin Products Offered
12.9.5 Octapharma Recent Development
12.10 Hualan Biological
12.10.1 Hualan Biological Corporation Information
12.10.2 Hualan Biological Description and Business Overview
12.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Products Offered
12.10.5 Hualan Biological Recent Development
12.11 Biotest
12.11.1 Biotest Corporation Information
12.11.2 Biotest Description and Business Overview
12.11.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Biotest Hepatitis B Human Immunoglobulin Products Offered
12.11.5 Biotest Recent Development
12.12 Tiantan Biologic
12.12.1 Tiantan Biologic Corporation Information
12.12.2 Tiantan Biologic Description and Business Overview
12.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Tiantan Biologic Products Offered
12.12.5 Tiantan Biologic Recent Development
12.13 Shuanglin Bio-pharmacy
12.13.1 Shuanglin Bio-pharmacy Corporation Information
12.13.2 Shuanglin Bio-pharmacy Description and Business Overview
12.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shuanglin Bio-pharmacy Products Offered
12.13.5 Shuanglin Bio-pharmacy Recent Development
12.14 Sichuan Yuanda Shuyang
12.14.1 Sichuan Yuanda Shuyang Corporation Information
12.14.2 Sichuan Yuanda Shuyang Description and Business Overview
12.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sichuan Yuanda Shuyang Products Offered
12.14.5 Sichuan Yuanda Shuyang Recent Development
12.15 Shanghai Institute of Biological
12.15.1 Shanghai Institute of Biological Corporation Information
12.15.2 Shanghai Institute of Biological Description and Business Overview
12.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Shanghai Institute of Biological Products Offered
12.15.5 Shanghai Institute of Biological Recent Development
12.16 Hualan
12.16.1 Hualan Corporation Information
12.16.2 Hualan Description and Business Overview
12.16.3 Hualan Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Hualan Products Offered
12.16.5 Hualan Recent Development
12.17 Shanghai RAAS Blood Products
12.17.1 Shanghai RAAS Blood Products Corporation Information
12.17.2 Shanghai RAAS Blood Products Description and Business Overview
12.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Shanghai RAAS Blood Products Products Offered
12.17.5 Shanghai RAAS Blood Products Recent Development
12.18 China Grand Enterprises
12.18.1 China Grand Enterprises Corporation Information
12.18.2 China Grand Enterprises Description and Business Overview
12.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.18.4 China Grand Enterprises Products Offered
12.18.5 China Grand Enterprises Recent Development
12.19 Nanyue Biopharmaceutical
12.19.1 Nanyue Biopharmaceutical Corporation Information
12.19.2 Nanyue Biopharmaceutical Description and Business Overview
12.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Nanyue Biopharmaceutical Products Offered
12.19.5 Nanyue Biopharmaceutical Recent Development
12.20 Boya Biopharmaceutical Group
12.20.1 Boya Biopharmaceutical Group Corporation Information
12.20.2 Boya Biopharmaceutical Group Description and Business Overview
12.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Boya Biopharmaceutical Group Products Offered
12.20.5 Boya Biopharmaceutical Group Recent Development
12.21 Tonglu Biopharmaceutical
12.21.1 Tonglu Biopharmaceutical Corporation Information
12.21.2 Tonglu Biopharmaceutical Description and Business Overview
12.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Tonglu Biopharmaceutical Products Offered
12.21.5 Tonglu Biopharmaceutical Recent Development
12.22 Shandong Taibang Biopharmaceutical
12.22.1 Shandong Taibang Biopharmaceutical Corporation Information
12.22.2 Shandong Taibang Biopharmaceutical Description and Business Overview
12.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Shandong Taibang Biopharmaceutical Products Offered
12.22.5 Shandong Taibang Biopharmaceutical Recent Development
12.23 Guangdong Shuanglin Biopharmaceutical
12.23.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
12.23.2 Guangdong Shuanglin Biopharmaceutical Description and Business Overview
12.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Guangdong Shuanglin Biopharmaceutical Products Offered
12.23.5 Guangdong Shuanglin Biopharmaceutical Recent Development
12.24 Chengdu Rongsheng Pharmaceutical
12.24.1 Chengdu Rongsheng Pharmaceutical Corporation Information
12.24.2 Chengdu Rongsheng Pharmaceutical Description and Business Overview
12.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Chengdu Rongsheng Pharmaceutical Products Offered
12.24.5 Chengdu Rongsheng Pharmaceutical Recent Development
12.25 Shenzhen Weiguang Biopharmaceutical
12.25.1 Shenzhen Weiguang Biopharmaceutical Corporation Information
12.25.2 Shenzhen Weiguang Biopharmaceutical Description and Business Overview
12.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Shenzhen Weiguang Biopharmaceutical Products Offered
12.25.5 Shenzhen Weiguang Biopharmaceutical Recent Development
12.26 Green Cross (China) Biological Products
12.26.1 Green Cross (China) Biological Products Corporation Information
12.26.2 Green Cross (China) Biological Products Description and Business Overview
12.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Green Cross (China) Biological Products Products Offered
12.26.5 Green Cross (China) Biological Products Recent Development
12.27 Sinopharm
12.27.1 Sinopharm Corporation Information
12.27.2 Sinopharm Description and Business Overview
12.27.3 Sinopharm Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Sinopharm Products Offered
12.27.5 Sinopharm Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Hepatitis B Human Immunoglobulin Industry Trends
13.2 Hepatitis B Human Immunoglobulin Market Drivers
13.3 Hepatitis B Human Immunoglobulin Market Challenges
13.4 Hepatitis B Human Immunoglobulin Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepatitis B Human Immunoglobulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer